Skip to content

Menu

LexBlog, Inc. logo
NetworkSub-MenuBrowse by SubjectBrowse by PublisherJoin the NetworkGet StartedSubscribeSupportContact
Search
Close

CMS Hears Opposition to Preliminary Decisions on HCPCS Codes at Second of Three Public Meetings

By Stuart M. Langbein & Beth Roberts on May 30, 2013
Email this postTweet this postLike this postShare this post on LinkedIn

Yesterday, CMS held the second of three public meetings to discuss preliminary decisions regarding applications for Healthcare Common Procedure Coding System (HCPCS) Level II codes.  Applicants submitted requests for new codes by early January, and CMS released preliminary decisions in response to those requests in April.  Those commenting on a preliminary decision are invited to be heard at a series of public meetings before CMS issues its final decisions in the fall.

The first of these meetings, held on May 8, 2013, addressed the preliminary decisions regard code requests for drugs, biologicals, and radiopharmaceuticals.  In its preliminary decisions, the HCPCS Workgroup proposed granting the majority of coding requests.

The second meeting, held yesterday, addressed supplies and “other” products and services.  Presenters supporting a dozen applications spoke at the meeting, opposing CMS’s preliminary decisions.  In its preliminary decisions, CMS did not grant a single applicant’s code request.  The limited interplay between speakers on behalf of applicants for a code and the HCPCS Workgroup suggests that many of the preliminary decisions issued may be finalized as proposed. 

Similarly, CMS’s preliminary decisions regarding Durable Medical Equipment (DME) and Accessories, to be discussed at the third public meeting on June 4, 2013, granted very few of the applicants’ requests.  Information about how to attend the final public meeting can be found on the CMS website.

Based on additional information and discussion at the public meetings, CMS may alter preliminary decisions.  Final decisions will released be in late October or early November.

 

  • Posted in:
    Health Care and Life Sciences
  • Blog:
    Focus on Regulation
  • Organization:
    Hogan Lovells
  • Article: View Original Source

Call us at 1-800-913-0988 or email sales@lexblog.com.

Facebook LinkedIn Twitter RSS
The Library at LexBlog
  • About LexBlog
  • The Field We Built
  • Library at LexBlog
  • Our Beliefs
  • Our Team
  • Contact LexBlog
  • Disclaimer
  • Editorial Policy
  • Terms of Service
  • Get Started
  • Publishing Solutions
  • Compass
  • Submit a Request
  • Support Center
  • System Status
Copyright © 2026, LexBlog, Inc. All Rights Reserved.
Law blog design & platform by LexBlog LexBlog Logo